Please log in to view this page
Username
Password
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
